Adenoviral delivery of an immunomodulatory protein to the tumor microenvironment controls tumor growth is a research paper published in Molecular Therapy — Oncolytics (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R21 AI122808
NIGMS NIH HHS
Grant: T32 GM142521
National Institutes of Health
Grant: 1R21AI122808-01
Novel Immunomodulating Therapeutics for HIV-1 Treatment
National Institutes of Health
FWCI
0.65
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity
Additional file 1 of SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity
Additional file 2 of SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity
Additional file 2 of SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity